News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
343,663 Results
Type
Article (26684)
Company Profile (39)
Press Release (316939)
Multimedia
Podcasts (219)
Webinars (8)
Section
Business (82025)
Career Advice (887)
Deals (13651)
Drug Delivery (83)
Drug Development (51786)
Employer Resources (69)
FDA (9591)
Job Trends (7240)
News (158451)
Policy (16297)
Tag
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (1908)
Accelerated approval (30)
Adcomms (19)
Allergies (91)
Alliances (19107)
ALS (134)
Alzheimer's disease (1304)
Antibody-drug conjugate (ADC) (244)
Approvals (9901)
Artificial intelligence (317)
Autoimmune disease (168)
Automation (25)
Bankruptcy (144)
Best Places to Work (6308)
BIOSECURE Act (13)
Biosimilars (79)
Biotechnology (18)
Bladder cancer (156)
Brain cancer (41)
Breast cancer (451)
Cancer (3668)
Cardiovascular disease (464)
Career advice (759)
Career pathing (21)
CAR-T (197)
CDC (50)
Celiac Disease (3)
Cell therapy (552)
Cervical cancer (30)
Clinical research (45386)
Collaboration (893)
Company closure (2)
Compensation (387)
Complete response letters (54)
COVID-19 (1457)
CRISPR (65)
C-suite (426)
Cystic fibrosis (93)
Data (5955)
Decentralized trials (2)
Denatured (80)
Depression (111)
Dermatology (56)
Diabetes (399)
Diagnostics (3610)
Digital health (27)
Diversity (7)
Diversity, equity & inclusion (25)
Drug discovery (131)
Drug pricing (140)
Drug shortages (24)
Duchenne muscular dystrophy (234)
Earnings (38210)
Editorial (35)
Employer branding (4)
Employer resources (63)
Events (53201)
Executive appointments (426)
FDA (12022)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (13)
Frontotemporal dementia (24)
Funding (767)
Gene editing (149)
Generative AI (23)
Gene therapy (545)
GLP-1 (703)
Government (2977)
Grass and pollen (3)
Guidances (297)
Healthcare (10601)
HIV (42)
Huntington's disease (24)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (78)
Immunology and inflammation (124)
Immuno-oncology (52)
Indications (121)
Infectious disease (1660)
Inflammatory bowel disease (115)
Inflation Reduction Act (12)
Influenza (65)
Intellectual property (160)
Interviews (118)
IPO (7027)
IRA (35)
Job creations (1149)
Job search strategy (674)
JPM (29)
Kidney cancer (19)
Labor market (27)
Layoffs (210)
Leadership (18)
Legal (2906)
Liver cancer (55)
Longevity (21)
Lung cancer (494)
Lymphoma (332)
Machine learning (29)
Management (26)
Manufacturing (428)
MASH (208)
Medical device (7243)
Medtech (7317)
Mergers & acquisitions (7194)
Metabolic disorders (1097)
mRNA (109)
Multiple sclerosis (107)
NASH (21)
Neurodegenerative disease (247)
Neuropsychiatric disorders (56)
Neuroscience (2240)
Neurotech (1)
NextGen: Class of 2026 (3336)
Non-profit (3079)
Now hiring (61)
Obesity (472)
Opinion (152)
Ovarian cancer (137)
Pain (179)
Pancreatic cancer (207)
Parkinson's disease (228)
Partnered (14)
Patents (287)
Patient recruitment (412)
Peanut (31)
People (24776)
Pharmaceutical (16)
Pharmacy benefit managers (19)
Phase 1 (13221)
Phase 2 (20050)
Phase 3 (15431)
Pipeline (5863)
Policy (222)
Postmarket research (2017)
Preclinical (6161)
Press Release (19)
Prostate cancer (191)
Psychedelics (32)
Radiopharmaceuticals (164)
Rare diseases (728)
Real estate (1866)
Recruiting (23)
Regulatory (13748)
Reports (16)
Research institute (1440)
Resumes & cover letters (120)
Rett syndrome (31)
RNA editing (16)
RSV (57)
Schizophrenia (119)
Series A (108)
Series B (81)
Service/supplier (1)
Sickle cell disease (85)
Special edition (9)
Spinal muscular atrophy (95)
Sponsored (21)
Startups (1435)
Stomach cancer (4)
Supply chain (52)
Tariffs (39)
The Weekly (136)
Vaccines (581)
Venture capital (51)
Weight loss (300)
Women's health (80)
Worklife (8)
Date
Last 7 days (397)
Last 30 days (1977)
Last 365 days (16230)
2026 (7040)
2025 (16488)
2024 (18916)
2023 (21265)
2022 (25898)
2021 (27880)
2020 (26796)
2019 (24067)
2018 (18139)
2017 (15732)
2016 (15103)
2015 (18133)
2014 (13149)
2013 (10536)
2012 (11330)
2011 (11868)
2010 (11111)
Location
Africa (333)
Alabama (64)
Alaska (3)
Arizona (156)
Arkansas (9)
Asia (17298)
Australia (3521)
California (7157)
Canada (1905)
China (715)
Colorado (305)
Connecticut (319)
Delaware (245)
Europe (43272)
Florida (1103)
Georgia (274)
Hawaii (1)
Idaho (26)
Illinois (623)
India (46)
Indiana (340)
Iowa (12)
Japan (307)
Kansas (82)
Kentucky (25)
Louisiana (32)
Maine (38)
Maryland (880)
Massachusetts (4640)
Michigan (158)
Minnesota (354)
Mississippi (4)
Missouri (76)
Montana (16)
Nebraska (15)
Nevada (76)
New Hampshire (43)
New Jersey (2197)
New Mexico (11)
New York (2070)
North Carolina (957)
North Dakota (6)
Northern California (3609)
Ohio (231)
Oklahoma (12)
Oregon (22)
Pennsylvania (1379)
Puerto Rico (15)
Rhode Island (13)
South America (542)
South Carolina (72)
South Dakota (1)
Southern California (2933)
Tennessee (130)
Texas (1100)
United States (25443)
Utah (207)
Vermont (1)
Virginia (175)
Washington D.C. (56)
Washington State (634)
West Virginia (1)
Wisconsin (46)
343,663 Results for "american heart association aha".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
November 4, 2025
·
1 min read
Press Releases
Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
May 7, 2026
·
7 min read
Press Releases
Innovent and SanegeneBio Announce Phase 1 Clinical Data for IBI3016 Presented at American Heart Association (AHA) 2025 Annual Meeting
November 10, 2025
·
10 min read
Press Releases
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
November 10, 2025
·
5 min read
Press Releases
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
April 10, 2026
·
2 min read
Press Releases
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 18, 2025
·
7 min read
Press Releases
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025
September 10, 2025
·
5 min read
Press Releases
Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
May 14, 2026
·
6 min read
Cardiovascular disease
Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025
Data presented at this year’s American Heart Association Scientific Sessions in New Orleans underline rapid advancements in the cardiovascular field.
November 11, 2025
·
5 min read
·
Tristan Manalac
Press Releases
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
November 4, 2025
·
8 min read
1 of 34,367
Next
